Market Overview

The Kerry Group plc (KRZ.IR) share price declined by 0.63 % during the 24‑hour trading period that concluded at 03:49 PM Central Europe on Thursday, 22 October 2026. The current trading price is approximately EUR 97.35. Market data indicate that 158.8 million shares are outstanding, giving the company a market capitalization of roughly EUR 15 billion. In the last 24 hours, about EUR 38.3 million of Kerry shares were traded, reflecting moderate liquidity.

Key technical indicators for Kerry include:

  • Simple moving average (200 days): EUR 77.38
  • 52‑week high: EUR 94.85 (21 October 2026)
  • 52‑week low: EUR 64.30 (24 March 2026)

Since the previous month‑end, Kerry shares have increased by 10.02 %.

Company Performance

Kerry Group plc reported that revenue for the first nine months of fiscal 2026 declined slightly, despite an increase in sales volume across its snack, meat, dairy, and beverage segments. The revenue dip was attributed to adverse pricing, currency, and portfolio effects that offset the volume gains.

The company has maintained its guidance for adjusted earnings per share (EPS) for 2026, projecting a modest growth rate in the low‑single‑digit range. Kerry also announced a new share‑buyback programme of up to €300 million following the completion of its current scheme, signalling confidence in its financial outlook.

Shares finished the trading day higher, reflecting positive market sentiment around the guidance and buy‑back announcement.

StockTrade ChangeCurrent PriceMarket CapP/E Ratio
Flutter Entertainment (FLUT)-0.91 %USD 78.61USD 13.6 bn–
Aptiv (APTV)-1.60 %USD 44.47USD 9.5 bn20.58
Allegion (ALLE)+1.25 %USD 169.54USD 13.4 bn20.54
Bank of Ireland (BIRG.IR)0 %EUR 18.29EUR 17.7 bn14.89
Glanbia (GL9.IR)+1.28 %EUR 20.38EUR 4.9 bn14.38

Glanbia PLC, an Irish ingredient and nutrition company, has been highlighted in a recent MarketsandMarkets report on the global microencapsulation market. The report lists Glanbia among leading firms with capabilities in encapsulation technologies, alongside BASF, DSM‑Firmenich, and Cargill. The analysis notes increasing demand for microencapsulation across pharmaceuticals, food and beverage, personal care, and agriculture, driven by the need to protect sensitive ingredients and enable controlled release. Glanbia’s involvement in developing encapsulated ingredients underscores its strategic role in providing high‑performance ingredients to diverse industries.

Company Profile

The Kerry Group PLC, together with its subsidiaries, specializes in developing, manufacturing, and delivering technology‑based taste and nutrition solutions for the food, beverage, and pharmaceutical industries. Its operations span Europe, the Middle East, Africa, the Americas, and the Asia Pacific, serving a broad range of customers across these regions.